Novarex노바렉스
194700 · KOSDAQ · ₩194700 · 노바렉스
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩37,478
vs the current price (₩9,070)
- Enterprise value
- ₩663B
- Equity value
- ₩684B
- WACC
- 7.3%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 313% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- To match today's price of ₩9,070, the model needs an operating margin of 3.1% every year (it uses 9.7%).
- Today's P/E is 3.9× against a typical 8.3× over the last 10 years.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- ₩21,971
- +142.2%
- Base
- ₩37,478
- +313.2%
- Bull
- ₩64,001
- +605.6%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (9.7%).
Revenue growth
- 12.8%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (12.8% a year, annual reports), fading to 3% by year 5.
- 10.4%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (12.8% a year, annual reports), fading to 3% by year 5.
- 7.9%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (12.8% a year, annual reports), fading to 3% by year 5.
- 5.5%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (12.8% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (12.8% a year, annual reports), fading to 3% by year 5.
Business
- 9.7%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 2.1%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 2.6%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- 21.2%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.03%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-27.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.1, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.53%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩436B
- Net debt (borrowings and leases − cash and deposits)
- −₩15B
- + Stakes and investments
- ₩6B
- Associates, long-term financial assets and deposits (book value)
- Shares
- 18,254,848
- Share price
- ₩9,070
- Market cap
- ₩166B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩301B | ₩296B | ₩403B | ₩492B | ₩543B | ₩586B | ₩619B | ₩637B |
| Growth | 7.3% | −1.7% | 36.1% | 12.8% | 10.4% | 7.9% | 5.5% | 3.0% |
| EBIT | ₩26B | ₩22B | ₩42B | ₩48B | ₩53B | ₩57B | ₩60B | ₩62B |
| EBIT margin | 8.5% | 7.3% | 10.4% | 9.7% | 9.7% | 9.7% | 9.7% | 9.7% |
| After-tax EBIT | ₩19B | ₩16B | ₩30B | ₩35B | ₩38B | ₩41B | ₩44B | ₩45B |
| + Depreciation | — | — | — | ₩10B | ₩11B | ₩12B | ₩13B | ₩13B |
| − Capital spending | ₩8.7B | ₩6.8B | ₩10B | ₩13B | ₩14B | ₩15B | ₩16B | ₩17B |
| − Working capital | ₩3.8B | ₩14B | ₩29B | ₩12B | ₩11B | ₩9.1B | ₩6.8B | ₩3.9B |
| Free cash flow | — | — | — | ₩20B | ₩25B | ₩29B | ₩34B | ₩38B |
| Discount factor | — | — | — | 0.932 | 0.868 | 0.809 | 0.753 | 0.702 |
| Present value | — | — | — | ₩19B | ₩21B | ₩24B | ₩25B | ₩26B |
Terminal value ₩780B, worth ₩548B today: 83% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩14,698 a share)Now 0.62× | ₩10,8510.74× | ₩15,3431.04× | ₩34,7632.37× |
| Price / earnings (last 12 months: ₩2,341 a share)Now 3.87× | ₩15,2376.51× | ₩19,5078.33× | ₩31,38413.4× |
| P/E on run-rate earnings (Q2 2026 × 4: ₩1,681 a share)Now 5.40× | ₩10,9416.51× | ₩14,0078.33× | ₩22,53513.4× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.3% | ₩39,829 | ₩42,760 | ₩46,362 | ₩50,896 | ₩56,784 |
| 6.8% | ₩36,294 | ₩38,636 | ₩41,458 | ₩44,925 | ₩49,289 |
| 7.3% | ₩33,321 | ₩35,224 | ₩37,478 | ₩40,193 | ₩43,529 |
| 7.8% | ₩30,788 | ₩32,354 | ₩34,184 | ₩36,352 | ₩38,964 |
| 8.3% | ₩28,603 | ₩29,907 | ₩31,413 | ₩33,173 | ₩35,258 |
Now (TTM)
- Market cap
- ₩166B
- Enterprise value
- ₩149B
- P/E
- 3.9×
- P/B
- 0.6×
- P/S
- 0.4×
- EV/EBITDA
- —
- Dividend yield
- 4.4%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩14,000 | ₩7,500 | ₩12,140 | ₩10,150 | ₩20,324 |
| Market cap | ₩256B | ₩137B | ₩222B | ₩185B | ₩371B |
| P/E | 7.3× | 6.1× | 10.0× | 9.2× | 14.0× |
| P/B | 1.0× | 0.6× | 1.1× | 1.0× | 2.7× |
| P/S | 0.6× | 0.5× | 0.7× | 0.7× | 1.3× |
| EV/EBITDA | — | — | — | — | — |
| Dividend yield | 2.9% | 2.7% | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| Novarex | 3.9× | 0.6× | 0.4× | — | 4.4% |
| Samyang Foods | 17.5× | 5.6× | 3.1× | — | 0.4% |
| Orion | 10.5× | 1.1× | 1.2× | 5.3× | 3.1% |
| CJ Cheiljedang | — | 0.3× | 0.1× | — | 3.6% |
| Nongshim | 12.1× | 0.8× | 0.7× | — | 1.5% |
| Otoki | 16.9× | 0.6× | 0.3× | — | 2.9% |
| Hite Jinro | 23.3× | 1.0× | 0.4× | 6.4× | 4.5% |
| Similar companies (median) | 16.9× | 0.9× | 0.6× | 5.8× | 3.0% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Novarex / 노바렉스 / 194700 / KRX:194700
Source: KRX statistical information